#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Ocular lymphoma Antiphospholipid syndrome Liver abscess Leiomyosarcoma Adenomatous polyposis coli Restless legs syndrome Warm autoimmune haemolytic anaemia Anti-neutrophil cytoplasmic antibody positive vasculitis Chronic hepatitis B Hodgkin's disease recurrent Bronchiolitis Adult T-cell lymphoma/leukaemia refractory Myocarditis Head and neck cancer More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Basic Information Angiosarcoma metastatic – Diagnostics Angiosarcoma non-metastatic Cystic fibrosis – Trials in Disease Cholangitis sclerosing – Basic Information Crigler-Najjar syndrome Systemic mastocytosis – Basic Information Proteus syndrome – Treatment Choroid melanoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vibosameran Piritramide Gimeracil Vsf1.01 Masupirdine Nemolizumab IPN01195 ZOLPIDEM TARTRATE OMECAMTIV MECARBIL Amcenestrant Gsk3965193B Trazodone Pf-07220060 Monohydrate Relebactam Iodine (123I) Iobenguane Acetylsalicylic Acid Ph. Eur. SGT-003 RO7795081 Pyridoxine Mps-216 More therapies…

    Learn about Your Condition

    Genitourinary tract neoplasm Medication overuse headache Urethral valves Seasonal allergy Carcinoid tumour pulmonary Hyperglycaemia Pancreatic carcinoma Eosinophilic oesophagitis Crohn's disease Fibrosarcoma metastatic Lumbosacral radiculopathy Biliary adenoma Prodromal Alzheimer's disease Osteoarthritis Anal cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
    France Italy Latvia Poland Slovakia Spain

  • Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    • Triptorelin
    Italy

  • Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biotinidase deficiency
    Investigated Drugs:
    • Biotin
    Spain

  • Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    Investigated Drugs:
    • Tisagenlecleucel
    Poland

  • Study on Menstrual Bleeding and Tolerability of Norgestimate and Ethinylestradiol for Women Using Contraceptives in Italy

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ethinylestradiol
    • NORGESTIMATE
    Italy

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9
Previous Page
1 … 805 806 807 808 809 … 1,659
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!